EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inactivation of Hes1 in Skeletal Undifferentiated Cells Increases Bone Volume

Ernesto Canalis iD, Emily Denker, Lauren Schilling

Endocrinology · 2026

DOI: 10.1210/endocr/bqag015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Ernesto Canalis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Orthopaedic Surgery, UConn Health, Farmington, CT 06030-4037, USA. Hauptthemen laut MEDLINE: Transcription Factor HES-1, Osteogenesis, Bone and Bones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leptin receptor positive (LepR+) cells are multipotent stromal cells and a source of osteogenic and adipogenic cells. Inactivation of Notch signaling in LepR+ cells increases bone mass in mature mice, but the target gene responsible was not identified. Because in LepR+ cells the expression of the Notch target gene Hes1 prevails over that of other genes, we explored the role of the Hes1 deletion in LepR+ cells. To this end, LepR-Cre;Hes1Δ/Δ mice were compared to Hes1loxP/loxP littermates. Male and female 5-month-old LepR-Cre;Hes1Δ/Δ mice exhibited an increase in femoral bone volume/total volume due to an increase in trabecular number; vertebral (L3) and cortical bone was not affected. Bone histomorphometry demonstrated decreased osteoclast number and eroded surface, decreased osteoblast number only in male mice, and no changes in bone formation. Neither osteogenesis nor adipogenesis was modified by the Hes1 deletion in bone marrow stromal cell cultures, although Tnfsf11 (encoding RANKL) was suppressed in osteogenic cultures of Hes1Δ/Δ cells. Single-cell RNA sequencing of femurs from 5-month-old LepR-Cre;Hes1Δ/Δ and control mice revealed the presence of 23 cell clusters including clusters composed of hematological cells (myeloid, B cells, and neutrophils), endothelial cells, and osteoblasts. There were no substantial differences in gene expression, cluster distribution, or trajectory finding between control and Hes1 inactivated cells. In conclusion, Hes1 inactivation in LepR+ cells results in an increase in bone mass secondary to a decrease in RANKL, osteoclast number, and bone resorption, but HES1 has little influence on osteogenesis or adipogenesis in bone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription Factor HES-1OsteogenesisBone and BonesAnimalsMaleMiceFemaleOsteoblastsReceptors, LeptinFemurCell DifferentiationAdipogenesisOsteoclastsRANK LigandMice, Knockout

Stichwörter der Autor:innen

Hes1LepRNotchadipogenesisbone volumeosteogenesis

Substanzen

Transcription Factor HES-1Hes1 protein, mouseReceptors, LeptinRANK Ligand

Autor:innen und Institutionen

  • Departments of Orthopaedic Surgery, UConn Health, Farmington, CT 06030-4037, USA.
  • Medicine, UConn Health, Farmington, CT 06030, USA.
  • UConn Musculoskeletal Institute, UConn Health, Farmington, CT 06030, USA.

ORCID-Profile: Ernesto Canalis

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

Canalis, E., Denker, E., & Schilling, L. (2026). Inactivation of Hes1 in Skeletal Undifferentiated Cells Increases Bone Volume. Endocrinology. https://doi.org/10.1210/endocr/bqag015

Vancouver

Canalis E, Denker E, Schilling L. Inactivation of Hes1 in Skeletal Undifferentiated Cells Increases Bone Volume. Endocrinology. 2026. doi:10.1210/endocr/bqag015

BibTeX
@article{Canalis2026,
  author = {Canalis, Ernesto and Denker, Emily and Schilling, Lauren},
  title = {Inactivation of Hes1 in Skeletal Undifferentiated Cells Increases Bone Volume},
  journal = {Endocrinology},
  year = {2026},
  doi = {10.1210/endocr/bqag015}
}
Kostenlos starten →